nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0229	0.0304	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0229	0.0304	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0198	0.0263	CbGbCtD
Zolpidem—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0198	0.0263	CbGbCtD
Zolpidem—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0192	0.0255	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0192	0.0255	CbGbCtD
Zolpidem—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.019	0.0252	CbGbCtD
Zolpidem—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0173	0.023	CbGbCtD
Zolpidem—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0173	0.023	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0173	0.023	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0173	0.023	CbGbCtD
Zolpidem—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0172	0.0228	CbGbCtD
Zolpidem—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0172	0.0228	CbGbCtD
Zolpidem—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0163	0.0216	CbGbCtD
Zolpidem—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0153	0.0203	CbGbCtD
Zolpidem—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.015	0.02	CbGbCtD
Zolpidem—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0148	0.0197	CbGbCtD
Zolpidem—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0144	0.0191	CbGbCtD
Zolpidem—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0141	0.0188	CbGbCtD
Zolpidem—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0141	0.0188	CbGbCtD
Zolpidem—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0138	0.0184	CbGbCtD
Zolpidem—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0138	0.0184	CbGbCtD
Zolpidem—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0135	0.018	CbGbCtD
Zolpidem—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.013	0.0173	CbGbCtD
Zolpidem—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.013	0.0173	CbGbCtD
Zolpidem—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0128	0.017	CbGbCtD
Zolpidem—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0127	0.0169	CbGbCtD
Zolpidem—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0127	0.0169	CbGbCtD
Zolpidem—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0124	0.0165	CbGbCtD
Zolpidem—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.012	0.0159	CbGbCtD
Zolpidem—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0116	0.0155	CbGbCtD
Zolpidem—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0116	0.0155	CbGbCtD
Zolpidem—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0116	0.0154	CbGbCtD
Zolpidem—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0115	0.0153	CbGbCtD
Zolpidem—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0115	0.0153	CbGbCtD
Zolpidem—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0107	0.0142	CbGbCtD
Zolpidem—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0105	0.014	CbGbCtD
Zolpidem—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0105	0.014	CbGbCtD
Zolpidem—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0105	0.0139	CbGbCtD
Zolpidem—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0105	0.0139	CbGbCtD
Zolpidem—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0101	0.0134	CbGbCtD
Zolpidem—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00994	0.0132	CbGbCtD
Zolpidem—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00968	0.0129	CbGbCtD
Zolpidem—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00965	0.0128	CbGbCtD
Zolpidem—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00909	0.0121	CbGbCtD
Zolpidem—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00882	0.0117	CbGbCtD
Zolpidem—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00872	0.0116	CbGbCtD
Zolpidem—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00872	0.0116	CbGbCtD
Zolpidem—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00836	0.0111	CbGbCtD
Zolpidem—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00798	0.0106	CbGbCtD
Zolpidem—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00798	0.0106	CbGbCtD
Zolpidem—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00787	0.0105	CbGbCtD
Zolpidem—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0074	0.00984	CbGbCtD
Zolpidem—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0074	0.00984	CbGbCtD
Zolpidem—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00669	0.0089	CbGbCtD
Zolpidem—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00669	0.0089	CbGbCtD
Zolpidem—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00578	0.00768	CbGbCtD
Zolpidem—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00561	0.00746	CbGbCtD
Zolpidem—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00507	0.00674	CbGbCtD
Zolpidem—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00507	0.00674	CbGbCtD
Zolpidem—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00486	0.00646	CbGbCtD
Zolpidem—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00102	0.0411	CbGeAlD
Zolpidem—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000834	0.0335	CbGeAlD
Zolpidem—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000814	0.0327	CbGeAlD
Zolpidem—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000804	0.0323	CbGeAlD
Zolpidem—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000792	0.0318	CbGeAlD
Zolpidem—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000723	0.0291	CbGeAlD
Zolpidem—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000604	0.0243	CbGeAlD
Zolpidem—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000594	0.0239	CbGeAlD
Zolpidem—GABRA3—nervous system—acquired immunodeficiency syndrome	0.00056	0.0225	CbGeAlD
Zolpidem—GABRB2—spinal cord—acquired immunodeficiency syndrome	0.000542	0.0218	CbGeAlD
Zolpidem—GABRG2—spinal cord—acquired immunodeficiency syndrome	0.000542	0.0218	CbGeAlD
Zolpidem—GABRA3—central nervous system—acquired immunodeficiency syndrome	0.000539	0.0217	CbGeAlD
Zolpidem—GABRB2—lung—acquired immunodeficiency syndrome	0.000493	0.0198	CbGeAlD
Zolpidem—GABRA1—spinal cord—acquired immunodeficiency syndrome	0.000479	0.0192	CbGeAlD
Zolpidem—GABRA2—vagina—acquired immunodeficiency syndrome	0.000476	0.0192	CbGeAlD
Zolpidem—GABRB2—nervous system—acquired immunodeficiency syndrome	0.000457	0.0184	CbGeAlD
Zolpidem—GABRG2—nervous system—acquired immunodeficiency syndrome	0.000457	0.0184	CbGeAlD
Zolpidem—GABRG2—central nervous system—acquired immunodeficiency syndrome	0.00044	0.0177	CbGeAlD
Zolpidem—GABRB2—central nervous system—acquired immunodeficiency syndrome	0.00044	0.0177	CbGeAlD
Zolpidem—GABRA3—brain—acquired immunodeficiency syndrome	0.000428	0.0172	CbGeAlD
Zolpidem—GABRA2—nervous system—acquired immunodeficiency syndrome	0.000417	0.0168	CbGeAlD
Zolpidem—GABRB3—spinal cord—acquired immunodeficiency syndrome	0.000416	0.0167	CbGeAlD
Zolpidem—GABRA1—nervous system—acquired immunodeficiency syndrome	0.000403	0.0162	CbGeAlD
Zolpidem—GABRA2—central nervous system—acquired immunodeficiency syndrome	0.000402	0.0161	CbGeAlD
Zolpidem—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000393	0.0158	CbGeAlD
Zolpidem—GABRA1—central nervous system—acquired immunodeficiency syndrome	0.000388	0.0156	CbGeAlD
Zolpidem—GABRB3—lung—acquired immunodeficiency syndrome	0.000379	0.0152	CbGeAlD
Zolpidem—CYP2C19—blood—acquired immunodeficiency syndrome	0.000374	0.015	CbGeAlD
Zolpidem—GABRB3—nervous system—acquired immunodeficiency syndrome	0.000351	0.0141	CbGeAlD
Zolpidem—GABRG2—brain—acquired immunodeficiency syndrome	0.000349	0.014	CbGeAlD
Zolpidem—GABRB2—brain—acquired immunodeficiency syndrome	0.000349	0.014	CbGeAlD
Zolpidem—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000347	0.014	CbGeAlD
Zolpidem—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000347	0.0139	CbGeAlD
Zolpidem—GABRB3—central nervous system—acquired immunodeficiency syndrome	0.000338	0.0136	CbGeAlD
Zolpidem—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000321	0.0129	CbGeAlD
Zolpidem—GABRA2—brain—acquired immunodeficiency syndrome	0.000319	0.0128	CbGeAlD
Zolpidem—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000309	0.0124	CbGeAlD
Zolpidem—GABRA1—brain—acquired immunodeficiency syndrome	0.000308	0.0124	CbGeAlD
Zolpidem—GABRA2—lymph node—acquired immunodeficiency syndrome	0.000308	0.0124	CbGeAlD
Zolpidem—CYP1A2—blood—acquired immunodeficiency syndrome	0.000305	0.0123	CbGeAlD
Zolpidem—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000304	0.0122	CbGeAlD
Zolpidem—CYP3A5—blood—acquired immunodeficiency syndrome	0.000295	0.0118	CbGeAlD
Zolpidem—CYP2C9—blood—acquired immunodeficiency syndrome	0.00029	0.0117	CbGeAlD
Zolpidem—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000278	0.0112	CbGeAlD
Zolpidem—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000273	0.011	CbGeAlD
Zolpidem—GABRB3—brain—acquired immunodeficiency syndrome	0.000268	0.0108	CbGeAlD
Zolpidem—CYP1A2—lung—acquired immunodeficiency syndrome	0.000268	0.0108	CbGeAlD
Zolpidem—PTGS1—blood—acquired immunodeficiency syndrome	0.000265	0.0106	CbGeAlD
Zolpidem—CYP3A5—lung—acquired immunodeficiency syndrome	0.000258	0.0104	CbGeAlD
Zolpidem—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000255	0.0103	CbGeAlD
Zolpidem—PTGS1—vagina—acquired immunodeficiency syndrome	0.000245	0.00987	CbGeAlD
Zolpidem—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000232	0.00933	CbGeAlD
Zolpidem—PTGS1—lung—acquired immunodeficiency syndrome	0.000232	0.00933	CbGeAlD
Zolpidem—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000228	0.00918	CbGeAlD
Zolpidem—CYP3A4—blood—acquired immunodeficiency syndrome	0.000221	0.00889	CbGeAlD
Zolpidem—CYP2D6—blood—acquired immunodeficiency syndrome	0.000218	0.00875	CbGeAlD
Zolpidem—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000215	0.00864	CbGeAlD
Zolpidem—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000207	0.00832	CbGeAlD
Zolpidem—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.00018	0.00722	CbGeAlD
Zolpidem—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000177	0.0071	CbGeAlD
Zolpidem—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000173	0.00695	CbGeAlD
Zolpidem—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.00017	0.00684	CbGeAlD
Zolpidem—PTGS1—brain—acquired immunodeficiency syndrome	0.000164	0.0066	CbGeAlD
Zolpidem—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000159	0.00638	CbGeAlD
Zolpidem—CYP2D6—brain—acquired immunodeficiency syndrome	0.000135	0.00543	CbGeAlD
Zolpidem—Myalgia—Ritonavir—acquired immunodeficiency syndrome	9.8e-05	0.00044	CcSEcCtD
Zolpidem—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	9.77e-05	0.000438	CcSEcCtD
Zolpidem—Anaemia—Lamivudine—acquired immunodeficiency syndrome	9.77e-05	0.000438	CcSEcCtD
Zolpidem—Anxiety—Ritonavir—acquired immunodeficiency syndrome	9.76e-05	0.000438	CcSEcCtD
Zolpidem—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	9.73e-05	0.000437	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	9.73e-05	0.000437	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.7e-05	0.000435	CcSEcCtD
Zolpidem—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.69e-05	0.000435	CcSEcCtD
Zolpidem—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.69e-05	0.000435	CcSEcCtD
Zolpidem—Anorexia—Delavirdine—acquired immunodeficiency syndrome	9.68e-05	0.000434	CcSEcCtD
Zolpidem—Discomfort—Ritonavir—acquired immunodeficiency syndrome	9.68e-05	0.000434	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.67e-05	0.000434	CcSEcCtD
Zolpidem—Cough—Saquinavir—acquired immunodeficiency syndrome	9.66e-05	0.000434	CcSEcCtD
Zolpidem—Angioedema—Lamivudine—acquired immunodeficiency syndrome	9.65e-05	0.000433	CcSEcCtD
Zolpidem—Pain—Indinavir—acquired immunodeficiency syndrome	9.61e-05	0.000431	CcSEcCtD
Zolpidem—Constipation—Indinavir—acquired immunodeficiency syndrome	9.61e-05	0.000431	CcSEcCtD
Zolpidem—Insomnia—Efavirenz—acquired immunodeficiency syndrome	9.6e-05	0.000431	CcSEcCtD
Zolpidem—Urticaria—Zidovudine—acquired immunodeficiency syndrome	9.6e-05	0.000431	CcSEcCtD
Zolpidem—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	9.58e-05	0.00043	CcSEcCtD
Zolpidem—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.56e-05	0.000429	CcSEcCtD
Zolpidem—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.55e-05	0.000429	CcSEcCtD
Zolpidem—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.55e-05	0.000429	CcSEcCtD
Zolpidem—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.54e-05	0.000428	CcSEcCtD
Zolpidem—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.53e-05	0.000428	CcSEcCtD
Zolpidem—Malaise—Lamivudine—acquired immunodeficiency syndrome	9.53e-05	0.000428	CcSEcCtD
Zolpidem—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.51e-05	0.000427	CcSEcCtD
Zolpidem—Nausea—Didanosine—acquired immunodeficiency syndrome	9.51e-05	0.000427	CcSEcCtD
Zolpidem—Vertigo—Lamivudine—acquired immunodeficiency syndrome	9.49e-05	0.000426	CcSEcCtD
Zolpidem—Hypotension—Delavirdine—acquired immunodeficiency syndrome	9.49e-05	0.000426	CcSEcCtD
Zolpidem—Syncope—Lamivudine—acquired immunodeficiency syndrome	9.48e-05	0.000425	CcSEcCtD
Zolpidem—Confusional state—Ritonavir—acquired immunodeficiency syndrome	9.47e-05	0.000425	CcSEcCtD
Zolpidem—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	9.46e-05	0.000425	CcSEcCtD
Zolpidem—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	9.46e-05	0.000424	CcSEcCtD
Zolpidem—Somnolence—Efavirenz—acquired immunodeficiency syndrome	9.44e-05	0.000423	CcSEcCtD
Zolpidem—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.43e-05	0.000423	CcSEcCtD
Zolpidem—Chest pain—Saquinavir—acquired immunodeficiency syndrome	9.43e-05	0.000423	CcSEcCtD
Zolpidem—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.43e-05	0.000423	CcSEcCtD
Zolpidem—Anxiety—Saquinavir—acquired immunodeficiency syndrome	9.4e-05	0.000422	CcSEcCtD
Zolpidem—Oedema—Ritonavir—acquired immunodeficiency syndrome	9.39e-05	0.000421	CcSEcCtD
Zolpidem—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.37e-05	0.00042	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	9.36e-05	0.00042	CcSEcCtD
Zolpidem—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	9.34e-05	0.000419	CcSEcCtD
Zolpidem—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.32e-05	0.000418	CcSEcCtD
Zolpidem—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	9.29e-05	0.000417	CcSEcCtD
Zolpidem—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.26e-05	0.000415	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.25e-05	0.000415	CcSEcCtD
Zolpidem—Shock—Ritonavir—acquired immunodeficiency syndrome	9.24e-05	0.000415	CcSEcCtD
Zolpidem—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.23e-05	0.000414	CcSEcCtD
Zolpidem—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	9.22e-05	0.000414	CcSEcCtD
Zolpidem—Cough—Lamivudine—acquired immunodeficiency syndrome	9.22e-05	0.000414	CcSEcCtD
Zolpidem—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.22e-05	0.000414	CcSEcCtD
Zolpidem—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	9.21e-05	0.000413	CcSEcCtD
Zolpidem—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.19e-05	0.000412	CcSEcCtD
Zolpidem—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	9.19e-05	0.000412	CcSEcCtD
Zolpidem—Insomnia—Delavirdine—acquired immunodeficiency syndrome	9.19e-05	0.000412	CcSEcCtD
Zolpidem—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	9.17e-05	0.000411	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	9.16e-05	0.000411	CcSEcCtD
Zolpidem—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.15e-05	0.000411	CcSEcCtD
Zolpidem—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.15e-05	0.000411	CcSEcCtD
Zolpidem—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	9.12e-05	0.000409	CcSEcCtD
Zolpidem—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.12e-05	0.000409	CcSEcCtD
Zolpidem—Confusional state—Saquinavir—acquired immunodeficiency syndrome	9.11e-05	0.000409	CcSEcCtD
Zolpidem—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	9.08e-05	0.000407	CcSEcCtD
Zolpidem—Pain—Efavirenz—acquired immunodeficiency syndrome	9.08e-05	0.000407	CcSEcCtD
Zolpidem—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.08e-05	0.000407	CcSEcCtD
Zolpidem—Rash—Nevirapine—acquired immunodeficiency syndrome	9.08e-05	0.000407	CcSEcCtD
Zolpidem—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.07e-05	0.000407	CcSEcCtD
Zolpidem—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	9.05e-05	0.000406	CcSEcCtD
Zolpidem—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.05e-05	0.000406	CcSEcCtD
Zolpidem—Oedema—Saquinavir—acquired immunodeficiency syndrome	9.04e-05	0.000406	CcSEcCtD
Zolpidem—Somnolence—Delavirdine—acquired immunodeficiency syndrome	9.03e-05	0.000405	CcSEcCtD
Zolpidem—Headache—Nevirapine—acquired immunodeficiency syndrome	9.02e-05	0.000405	CcSEcCtD
Zolpidem—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9e-05	0.000404	CcSEcCtD
Zolpidem—Chest pain—Lamivudine—acquired immunodeficiency syndrome	9e-05	0.000404	CcSEcCtD
Zolpidem—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9e-05	0.000404	CcSEcCtD
Zolpidem—Infection—Saquinavir—acquired immunodeficiency syndrome	8.98e-05	0.000403	CcSEcCtD
Zolpidem—Anxiety—Lamivudine—acquired immunodeficiency syndrome	8.96e-05	0.000402	CcSEcCtD
Zolpidem—Anorexia—Ritonavir—acquired immunodeficiency syndrome	8.95e-05	0.000402	CcSEcCtD
Zolpidem—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	8.94e-05	0.000401	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	8.93e-05	0.000401	CcSEcCtD
Zolpidem—Urticaria—Indinavir—acquired immunodeficiency syndrome	8.92e-05	0.000401	CcSEcCtD
Zolpidem—Shock—Saquinavir—acquired immunodeficiency syndrome	8.89e-05	0.000399	CcSEcCtD
Zolpidem—Discomfort—Lamivudine—acquired immunodeficiency syndrome	8.89e-05	0.000399	CcSEcCtD
Zolpidem—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	8.88e-05	0.000399	CcSEcCtD
Zolpidem—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	8.88e-05	0.000399	CcSEcCtD
Zolpidem—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	8.86e-05	0.000398	CcSEcCtD
Zolpidem—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	8.86e-05	0.000398	CcSEcCtD
Zolpidem—Vomiting—Stavudine—acquired immunodeficiency syndrome	8.84e-05	0.000397	CcSEcCtD
Zolpidem—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	8.83e-05	0.000396	CcSEcCtD
Zolpidem—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	8.8e-05	0.000395	CcSEcCtD
Zolpidem—Rash—Nelfinavir—acquired immunodeficiency syndrome	8.79e-05	0.000394	CcSEcCtD
Zolpidem—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	8.78e-05	0.000394	CcSEcCtD
Zolpidem—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	8.78e-05	0.000394	CcSEcCtD
Zolpidem—Hypotension—Ritonavir—acquired immunodeficiency syndrome	8.78e-05	0.000394	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	8.77e-05	0.000393	CcSEcCtD
Zolpidem—Rash—Stavudine—acquired immunodeficiency syndrome	8.76e-05	0.000393	CcSEcCtD
Zolpidem—Fatigue—Delavirdine—acquired immunodeficiency syndrome	8.76e-05	0.000393	CcSEcCtD
Zolpidem—Dermatitis—Stavudine—acquired immunodeficiency syndrome	8.75e-05	0.000393	CcSEcCtD
Zolpidem—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	8.75e-05	0.000393	CcSEcCtD
Zolpidem—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	8.74e-05	0.000392	CcSEcCtD
Zolpidem—Headache—Nelfinavir—acquired immunodeficiency syndrome	8.73e-05	0.000392	CcSEcCtD
Zolpidem—Headache—Stavudine—acquired immunodeficiency syndrome	8.71e-05	0.000391	CcSEcCtD
Zolpidem—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.7e-05	0.000391	CcSEcCtD
Zolpidem—Confusional state—Lamivudine—acquired immunodeficiency syndrome	8.69e-05	0.00039	CcSEcCtD
Zolpidem—Pain—Delavirdine—acquired immunodeficiency syndrome	8.68e-05	0.00039	CcSEcCtD
Zolpidem—Constipation—Delavirdine—acquired immunodeficiency syndrome	8.68e-05	0.00039	CcSEcCtD
Zolpidem—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.68e-05	0.00039	CcSEcCtD
Zolpidem—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.67e-05	0.000389	CcSEcCtD
Zolpidem—Rash—Abacavir—acquired immunodeficiency syndrome	8.63e-05	0.000387	CcSEcCtD
Zolpidem—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.62e-05	0.000387	CcSEcCtD
Zolpidem—Oedema—Lamivudine—acquired immunodeficiency syndrome	8.62e-05	0.000387	CcSEcCtD
Zolpidem—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	8.62e-05	0.000387	CcSEcCtD
Zolpidem—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.62e-05	0.000387	CcSEcCtD
Zolpidem—Headache—Abacavir—acquired immunodeficiency syndrome	8.58e-05	0.000385	CcSEcCtD
Zolpidem—Infection—Lamivudine—acquired immunodeficiency syndrome	8.57e-05	0.000384	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.56e-05	0.000384	CcSEcCtD
Zolpidem—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.55e-05	0.000384	CcSEcCtD
Zolpidem—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.55e-05	0.000384	CcSEcCtD
Zolpidem—Insomnia—Ritonavir—acquired immunodeficiency syndrome	8.49e-05	0.000381	CcSEcCtD
Zolpidem—Shock—Lamivudine—acquired immunodeficiency syndrome	8.48e-05	0.000381	CcSEcCtD
Zolpidem—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.46e-05	0.000379	CcSEcCtD
Zolpidem—Hypotension—Saquinavir—acquired immunodeficiency syndrome	8.45e-05	0.000379	CcSEcCtD
Zolpidem—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.43e-05	0.000378	CcSEcCtD
Zolpidem—Urticaria—Efavirenz—acquired immunodeficiency syndrome	8.43e-05	0.000378	CcSEcCtD
Zolpidem—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.39e-05	0.000377	CcSEcCtD
Zolpidem—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.39e-05	0.000377	CcSEcCtD
Zolpidem—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	8.38e-05	0.000376	CcSEcCtD
Zolpidem—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.37e-05	0.000376	CcSEcCtD
Zolpidem—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.37e-05	0.000376	CcSEcCtD
Zolpidem—Somnolence—Ritonavir—acquired immunodeficiency syndrome	8.35e-05	0.000375	CcSEcCtD
Zolpidem—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.000374	CcSEcCtD
Zolpidem—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.3e-05	0.000373	CcSEcCtD
Zolpidem—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.28e-05	0.000372	CcSEcCtD
Zolpidem—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.28e-05	0.000371	CcSEcCtD
Zolpidem—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	8.27e-05	0.000371	CcSEcCtD
Zolpidem—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.26e-05	0.000371	CcSEcCtD
Zolpidem—Nausea—Stavudine—acquired immunodeficiency syndrome	8.26e-05	0.00037	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.24e-05	0.00037	CcSEcCtD
Zolpidem—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.22e-05	0.000369	CcSEcCtD
Zolpidem—Insomnia—Saquinavir—acquired immunodeficiency syndrome	8.18e-05	0.000367	CcSEcCtD
Zolpidem—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.16e-05	0.000366	CcSEcCtD
Zolpidem—Nausea—Abacavir—acquired immunodeficiency syndrome	8.13e-05	0.000365	CcSEcCtD
Zolpidem—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.12e-05	0.000364	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.11e-05	0.000364	CcSEcCtD
Zolpidem—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.1e-05	0.000363	CcSEcCtD
Zolpidem—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.07e-05	0.000362	CcSEcCtD
Zolpidem—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.06e-05	0.000362	CcSEcCtD
Zolpidem—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.06e-05	0.000362	CcSEcCtD
Zolpidem—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.06e-05	0.000362	CcSEcCtD
Zolpidem—Somnolence—Saquinavir—acquired immunodeficiency syndrome	8.04e-05	0.000361	CcSEcCtD
Zolpidem—Pain—Ritonavir—acquired immunodeficiency syndrome	8.03e-05	0.00036	CcSEcCtD
Zolpidem—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.03e-05	0.00036	CcSEcCtD
Zolpidem—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.03e-05	0.00036	CcSEcCtD
Zolpidem—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.03e-05	0.00036	CcSEcCtD
Zolpidem—Dizziness—Zidovudine—acquired immunodeficiency syndrome	7.99e-05	0.000358	CcSEcCtD
Zolpidem—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	7.96e-05	0.000357	CcSEcCtD
Zolpidem—Pruritus—Indinavir—acquired immunodeficiency syndrome	7.95e-05	0.000357	CcSEcCtD
Zolpidem—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	7.86e-05	0.000353	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	7.86e-05	0.000353	CcSEcCtD
Zolpidem—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	7.82e-05	0.000351	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	7.8e-05	0.00035	CcSEcCtD
Zolpidem—Insomnia—Lamivudine—acquired immunodeficiency syndrome	7.8e-05	0.00035	CcSEcCtD
Zolpidem—Fatigue—Saquinavir—acquired immunodeficiency syndrome	7.79e-05	0.00035	CcSEcCtD
Zolpidem—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	7.74e-05	0.000347	CcSEcCtD
Zolpidem—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	7.74e-05	0.000347	CcSEcCtD
Zolpidem—Pain—Saquinavir—acquired immunodeficiency syndrome	7.73e-05	0.000347	CcSEcCtD
Zolpidem—Constipation—Saquinavir—acquired immunodeficiency syndrome	7.73e-05	0.000347	CcSEcCtD
Zolpidem—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	7.69e-05	0.000345	CcSEcCtD
Zolpidem—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.69e-05	0.000345	CcSEcCtD
Zolpidem—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.68e-05	0.000345	CcSEcCtD
Zolpidem—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.68e-05	0.000345	CcSEcCtD
Zolpidem—Somnolence—Lamivudine—acquired immunodeficiency syndrome	7.67e-05	0.000344	CcSEcCtD
Zolpidem—Rash—Zidovudine—acquired immunodeficiency syndrome	7.62e-05	0.000342	CcSEcCtD
Zolpidem—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.62e-05	0.000342	CcSEcCtD
Zolpidem—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.61e-05	0.000341	CcSEcCtD
Zolpidem—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.59e-05	0.000341	CcSEcCtD
Zolpidem—Headache—Zidovudine—acquired immunodeficiency syndrome	7.57e-05	0.00034	CcSEcCtD
Zolpidem—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.51e-05	0.000337	CcSEcCtD
Zolpidem—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.5e-05	0.000336	CcSEcCtD
Zolpidem—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.48e-05	0.000336	CcSEcCtD
Zolpidem—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.46e-05	0.000335	CcSEcCtD
Zolpidem—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.45e-05	0.000334	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.44e-05	0.000334	CcSEcCtD
Zolpidem—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.43e-05	0.000334	CcSEcCtD
Zolpidem—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.43e-05	0.000333	CcSEcCtD
Zolpidem—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.42e-05	0.000333	CcSEcCtD
Zolpidem—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.42e-05	0.000333	CcSEcCtD
Zolpidem—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.39e-05	0.000332	CcSEcCtD
Zolpidem—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.37e-05	0.000331	CcSEcCtD
Zolpidem—Pain—Lamivudine—acquired immunodeficiency syndrome	7.37e-05	0.000331	CcSEcCtD
Zolpidem—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.29e-05	0.000327	CcSEcCtD
Zolpidem—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.26e-05	0.000326	CcSEcCtD
Zolpidem—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.18e-05	0.000322	CcSEcCtD
Zolpidem—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.18e-05	0.000322	CcSEcCtD
Zolpidem—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.18e-05	0.000322	CcSEcCtD
Zolpidem—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000321	CcSEcCtD
Zolpidem—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000321	CcSEcCtD
Zolpidem—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.14e-05	0.000321	CcSEcCtD
Zolpidem—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.000319	CcSEcCtD
Zolpidem—Rash—Indinavir—acquired immunodeficiency syndrome	7.08e-05	0.000318	CcSEcCtD
Zolpidem—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.08e-05	0.000318	CcSEcCtD
Zolpidem—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.05e-05	0.000316	CcSEcCtD
Zolpidem—Headache—Indinavir—acquired immunodeficiency syndrome	7.04e-05	0.000316	CcSEcCtD
Zolpidem—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.02e-05	0.000315	CcSEcCtD
Zolpidem—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	6.95e-05	0.000312	CcSEcCtD
Zolpidem—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	6.92e-05	0.000311	CcSEcCtD
Zolpidem—Urticaria—Lamivudine—acquired immunodeficiency syndrome	6.85e-05	0.000307	CcSEcCtD
Zolpidem—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	6.82e-05	0.000306	CcSEcCtD
Zolpidem—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	6.82e-05	0.000306	CcSEcCtD
Zolpidem—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.75e-05	0.000303	CcSEcCtD
Zolpidem—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.74e-05	0.000302	CcSEcCtD
Zolpidem—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.72e-05	0.000301	CcSEcCtD
Zolpidem—Rash—Efavirenz—acquired immunodeficiency syndrome	6.69e-05	0.0003	CcSEcCtD
Zolpidem—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.69e-05	0.0003	CcSEcCtD
Zolpidem—Nausea—Indinavir—acquired immunodeficiency syndrome	6.67e-05	0.000299	CcSEcCtD
Zolpidem—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.66e-05	0.000299	CcSEcCtD
Zolpidem—Headache—Efavirenz—acquired immunodeficiency syndrome	6.65e-05	0.000298	CcSEcCtD
Zolpidem—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.64e-05	0.000298	CcSEcCtD
Zolpidem—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.49e-05	0.000291	CcSEcCtD
Zolpidem—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.46e-05	0.00029	CcSEcCtD
Zolpidem—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.43e-05	0.000288	CcSEcCtD
Zolpidem—Rash—Delavirdine—acquired immunodeficiency syndrome	6.4e-05	0.000287	CcSEcCtD
Zolpidem—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.4e-05	0.000287	CcSEcCtD
Zolpidem—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.4e-05	0.000287	CcSEcCtD
Zolpidem—Headache—Delavirdine—acquired immunodeficiency syndrome	6.36e-05	0.000286	CcSEcCtD
Zolpidem—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.35e-05	0.000285	CcSEcCtD
Zolpidem—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.3e-05	0.000283	CcSEcCtD
Zolpidem—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.21e-05	0.000279	CcSEcCtD
Zolpidem—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.19e-05	0.000278	CcSEcCtD
Zolpidem—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.18e-05	0.000278	CcSEcCtD
Zolpidem—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.1e-05	0.000274	CcSEcCtD
Zolpidem—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.03e-05	0.000271	CcSEcCtD
Zolpidem—Dizziness—Saquinavir—acquired immunodeficiency syndrome	5.98e-05	0.000268	CcSEcCtD
Zolpidem—Vomiting—Ritonavir—acquired immunodeficiency syndrome	5.97e-05	0.000268	CcSEcCtD
Zolpidem—Rash—Ritonavir—acquired immunodeficiency syndrome	5.92e-05	0.000266	CcSEcCtD
Zolpidem—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	5.92e-05	0.000265	CcSEcCtD
Zolpidem—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	5.9e-05	0.000265	CcSEcCtD
Zolpidem—Headache—Ritonavir—acquired immunodeficiency syndrome	5.88e-05	0.000264	CcSEcCtD
Zolpidem—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.75e-05	0.000258	CcSEcCtD
Zolpidem—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.7e-05	0.000256	CcSEcCtD
Zolpidem—Rash—Saquinavir—acquired immunodeficiency syndrome	5.7e-05	0.000256	CcSEcCtD
Zolpidem—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.69e-05	0.000256	CcSEcCtD
Zolpidem—Headache—Saquinavir—acquired immunodeficiency syndrome	5.66e-05	0.000254	CcSEcCtD
Zolpidem—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.58e-05	0.00025	CcSEcCtD
Zolpidem—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.48e-05	0.000246	CcSEcCtD
Zolpidem—Rash—Lamivudine—acquired immunodeficiency syndrome	5.44e-05	0.000244	CcSEcCtD
Zolpidem—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.43e-05	0.000244	CcSEcCtD
Zolpidem—Headache—Lamivudine—acquired immunodeficiency syndrome	5.4e-05	0.000242	CcSEcCtD
Zolpidem—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.37e-05	0.000241	CcSEcCtD
Zolpidem—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.12e-05	0.00023	CcSEcCtD
